ArticleNeuroradiology2025
Evaluation of an abbreviated MRI protocol in the screening for brain metastases in the initial staging of lung cancer.
Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeIn the routine clinical practice, only a few key sequences allow positive diagnosis of brain metastasis. The aim of our study was to investigate the diagnostic accuracy of a reduced protocol including only 2 sequences of interest for the detection of brain lesions in lung cancer. MATERIALS AND
methodsFifty four patients undergoing MRI in the initial staging of lung cancer were included in this monocentric, retrospective study. Four radiologists reviewed the data from a short protocol with 2 sequences of interest (3D FLAIR and 3D T1w-SE sequences) and from the standard reference protocol (DWI, T2*, 3D FLAIR, non-enhanced T1, post-contrast 3D T1w-GRE and post-contrast 3D T1w-SE sequences). Diagnostic performances were assessed on a per-patient and per-lesion basis.
resultsIn our population, 35% of patients had brain metastases. The short protocol detected 22 metastatic patients with 3 false positives. The analysis showed excellent diagnostic performance of the short protocol with more than 90% sensitivity and specificity, for both per-patient and per-lesion evaluations. Metastatic classification was not significantly influenced by the reviewer's experience. Seven major secondary findings were identified, including 3 ischemic events and 1 aneurysm that were only detected when the long protocol was used.
conclusionsA short MRI brain protocol, including only 3D FLAIR and post-contrast T1w-SE sequences, demonstrated diagnostic accuracy equivalent to standard protocols for BM screening in lung cancer patients. The subsequent reduction in examination time can potentially improve access to MRI.
Indexed as
Identifiers
41137927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.